Feng‐Liang Liu
- Virology top 5%
- HIV Research and Treatment 21
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 5
- Hepatology top 10%
- Hepatitis C virus research 6
-
- Immune Cell Function and Interaction 9
- interferon and immune responses 6
-
- Virology and Viral Diseases 3
-
- Multiferroics and related materials 4
- Journals
- Physical review. B. (3 papers)Asian Journal of Andrology (3 papers)npj Quantum Materials (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Feng‐Liang Liu
67 papers receiving 997 citations
Peers
Comparison fields: 5 of 129
- Virology 195
- Infectious Diseases 311
- Hepatology 96
- Immunology 196
- Epidemiology 214
Countries citing papers authored by Feng‐Liang Liu
This map shows the geographic impact of Feng‐Liang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Liang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Liang Liu more than expected).
Fields of papers citing papers by Feng‐Liang Liu
This network shows the impact of papers produced by Feng‐Liang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Liang Liu. The network helps show where Feng‐Liang Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feng‐Liang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 4 | |
| 9 | 2020 | 43 | |
| 10 | 2019 | 10 | |
| 11 | 2017 | 31 | |
| 12 | 2017 | 12 | |
| 13 | 2016 | 2 | |
| 14 | 2016 | 5 | |
| 15 | 2015 | 4 | |
| 16 | 2015 | 4 | |
| 17 | 2015 | 11 | |
| 18 | 2014 | 13 | |
| 19 | 2012 | 53 | |
| 20 | 2012 | 6 |
About Feng‐Liang Liu
Feng‐Liang Liu is a scholar working on Virology, Immunology and Hepatology, having authored 73 papers that have together received 1.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (21 papers), Immune Cell Function and Interaction (9 papers), COVID-19 Clinical Research Studies (7 papers), interferon and immune responses (6 papers), Hepatitis C virus research (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Multiferroics and related materials (4 papers) and Virology and Viral Diseases (3 papers). The work is most often cited by research in Virology (195 citations), Infectious Diseases (311 citations) and Hepatology (96 citations). Feng‐Liang Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yong‐Tang Zheng, Yan-Heng Zhou, Zhihong Yao, Hong Li, Jiawu Zhu, Song Xue, Ming Zeng, Sheng-Peng Sun, Lin Duo and Wenge Yang. Their work appears in journals such as Physical review. B., Asian Journal of Andrology, npj Quantum Materials, PLoS ONE and National Science Review.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.